The first stage of the project is the E-Referral portal, which will go live in February 2024. Previously, external referrals were delaying patient journeys due to paper processes within the trust. Once live, referrals will be digital and instantly received by the trust, reducing paper referrals. Additionally, patients will be able to see their referrals in the portal and enable them to keep track of where they are in their cancer journey.
Simultaneously, the trust and Avenue3 are developing and implementing the Patient Engagement Portal, built on openEHR standards, this will feed into the existing Patient Administration System (PAS) and also link with the E-Referral system. Serving as a centralised portal for all patient communications and information.
In the portal, patients will have access to a single landing page with information on their diagnosis, upcoming appointments, treatment plans, and cancer journey, further improving patient experience. The portal will also have the option to send appointments invitations via SMS or email, depending on patient preference.
Up until now, the trust has largely used paper-based patient communications for appointments and treatment information. Speaking on the importance of the project, Patricia Reilly, Head of Digital Programmes at The Christie NHS Foundation Trust said: “As the largest single-site cancer centre in Europe, serving a population of more than 60,000 patients a year, we’re always looking for ways to improve care for patients.”
“It can often be a difficult time for patients undergoing cancer treatment, it’s important that we can make every interaction with the trust as seamless as possible, notifying patients about appointments in a timely manner and communicating important information to their digital or non-digital preferences. Both solutions will not only streamline workflows for clinicians but enhance communication and engagement for patients and ultimately improve referral processes.”
Once complete, the project will benefit clinicians as well as patients, by streamlining workflows and reducing paper usage, all while being built on openEHR standards.
“It was important that we partnered with a provider that is passionate about digital transformation and openEHR as we are at The Christie. From the beginning, Avenue3 understood the nuances of the NHS and healthcare, and why effective communication is important for cancer patients” Patricia continued.
Phil Bottomley, Founder & Director at Avenue3 said: “We are delighted to have been chosen to partner with The Christie on this innovative open data project which will empower patients and shift care into the home. Delivering at pace in collaboration with clinicians, patients and digital teams is one of our greatest strengths.”
